The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk stratified multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program for women with gynecological cancers: Preliminary results from a prospective single-center study.
 
Shiru Lucy Liu
No Relationships to Disclose
 
Yeh Chen Lee
Travel, Accommodations, Expenses - AstraZeneca
 
Nazlin Jivraj
No Relationships to Disclose
 
Valerie Bowering
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Lisa Wang
No Relationships to Disclose
 
Gita Bhat
No Relationships to Disclose
 
Ainhoa Madariaga
No Relationships to Disclose
 
Lawrence Kasherman
No Relationships to Disclose
 
Kashish Nathwani
No Relationships to Disclose
 
Azieb Tesfu
No Relationships to Disclose
 
Sarah Lee
No Relationships to Disclose
 
Sarah E. Ferguson
No Relationships to Disclose
 
Jennifer M. Croke
No Relationships to Disclose
 
Catherine O'Brien
No Relationships to Disclose
 
Jenny Lau
No Relationships to Disclose
 
Tanya Chawla
No Relationships to Disclose
 
Eran Schlomovitz
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)